Innovation over Regulation Urged for Families

For our kids’ sakes, innovation should be encouraged, not stifled by unnecessary regulation, according to a parent and business owner. New technologies and advancements are making parenthood easier and offering hope for serious medical conditions. However, restrictive policies could hinder progress and limit access to beneficial tools and treatments.

The author shared a personal experience from January 28, 2025, when an AI chatbot recommended the emergency room for their daughter. While the daughter ultimately lost her appendix, the parents recognized the potential of modern innovation to assist families. This perspective highlights how technology can simplify daily tasks, allowing parents to focus more on their children or professional responsibilities.

Innovation’s Impact on Health and Daily Life

Recent breakthroughs underscore the positive impact of innovation. Researchers have announced a daily oral pill that can double the median overall survival for metastatic pancreatic cancer patients. Additionally, an experimental drug has shown the ability to slow cognitive and functional decline in Alzheimer’s patients by up to 50 percent. New treatments are also now capable of functionally curing sickle cell disease.

In contrast, social media often amplifies fears by presenting rare medical tragedies as highly probable. The steady stream of medical advancements, however, provides a more optimistic outlook. These developments offer parents a reason to enjoy the present with their children rather than dwelling on potential future anxieties. For families juggling multiple responsibilities, like homeschooling and running a business, consumer-facing technology can significantly lighten the load. These tools manage administrative tasks, freeing up time for teaching children or serving clients.

The author emphasizes that these innovations do not replace parental roles but rather support them. They make it easier for parents to concentrate on what is most important. The primary concern is not technology itself, but rather excessive bureaucracy and heavy-handed rules.

Regulation vs. Innovation

Lawmakers in Lincoln considered bills to regulate AI and other technologies earlier this year. The author argues that these proposals often fail to address why existing laws cannot hold bad actors accountable. Instead of new regulations that could remove useful tools from parents or burden small startups with compliance costs, existing statutes prohibiting discrimination, fraud, and other harmful actions should be enforced.

Policies in Washington can also impact access to innovation, particularly concerning drug pricing. The concept of most-favored-nation (MFN) pricing, which ties U.S. government payments for pharmaceuticals to prices paid by European countries, is cited as an example. While appearing to offer savings, importing foreign price controls could limit access to treatments for American patients and slow future medical development.

Studies suggest that an MFN pricing regime could reduce U.S. drug-innovation revenue by nearly half. This could lead to approximately 210 fewer new drug approvals and 290 fewer post-approval indications over 10 years. Such outcomes represent potentially life-improving and life-saving treatments that future generations might not experience.

Policymakers are urged not to choose between affordability and progress or safety and innovation. Instead, they should leverage existing laws to hold irresponsible parties accountable. Health regulations should foster the development of new treatments, rather than implementing price-control measures that may offer short-term political gains at the expense of future cures. American innovation is enhancing health prospects for children and providing parents with better tools. Policies should be designed to encourage both of these advancements for the benefit of all families.